Sanofi SNY
NASDAQ SNY
$41.96 +0.99 (+2.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Sanofi (SNY) Profit After Tax (2009 - 2026)

Updated

Sanofi's Profit After Tax came in at $2.16 billion for the quarter ended Jun 30, 2026, down 1.9% from $2.21 billion a year earlier and down 33.5% from the prior quarter.

Analysis

Sanofi (SNY) Profit After Tax (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sanofi reported Profit After Tax of $9.64 billion, down 29.4% year-over-year; for the year ended Dec 31, 2025, it came in at $5.8 billion, down 46.7% from the prior year.

  • Profit After Tax carries a five-year compound annual growth rate of 23.1% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Profit After Tax was $10.88 billion in the year ended Dec 31, 2024 (+92.1%), $5.66 billion in the year ended Dec 31, 2023 (-57.7%), $13.39 billion in the year ended Dec 31, 2022 (+633.2%) and $1.83 billion in the year ended Dec 31, 2021 (-10.9%).
  • The five-year range for quarterly Profit After Tax is -$7.07 billion (the quarter ended Dec 31, 2025) to $11.29 billion (the quarter ended Sep 30, 2025).
  • Year-over-year, Profit After Tax increased in four of the last seven quarters, with growth averaging 17.8%.
  • The fastest year-over-year change in Profit After Tax over five years came in the quarter ended Dec 31, 2022 (growth of 279.2%), and the weakest in the quarter ended Dec 31, 2024 (a decline of 68.9%).
  • Business Quant data shows SNY's Profit After Tax at $3.25 billion (quarter ended Mar 31, 2026), -$7.07 billion (quarter ended Dec 31, 2025) and $11.29 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,139.85 Bn 1,108.44 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 634.68 Bn 554.54 Bn 17.30 Bn 210.00 Mn
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn 3.62 Bn
4 Merck 354.57 Bn 308.95 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 300.14 Bn 264.13 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 263.08 Bn 236.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.91 Bn 193.31 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 193.96 Bn 168.15 Bn 6.22 Bn -10.50 Bn
9 Pfizer 170.07 Bn 116.71 Bn 10.94 Bn -246.00 Mn
10 Sanofi 50.49 Bn 17.01 Bn 10.79 Bn -941.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -941.51 Mn
Mar 31, 2026 3.25 Bn
Dec 31, 2025 -3.82 Bn
Sep 30, 2025 11.29 Bn
Jun 30, 2025 -219.60 Mn
Mar 31, 2025 3.22 Bn
Dec 31, 2024 3.16 Bn
Sep 30, 2024 5.06 Bn
Jun 30, 2024 375.83 Mn
Mar 31, 2024 1.88 Bn
Dec 31, 2023 2.04 Bn
Sep 30, 2023 4.61 Bn
Jun 30, 2023 279.85 Mn
Mar 31, 2023 3.49 Bn
Dec 31, 2022 5.39 Bn
Sep 30, 2022 3.51 Bn
Jun 30, 2022 375.60 Mn
Mar 31, 2022 3.17 Bn
Dec 31, 2021 289.88 Mn
Sep 30, 2021 4.40 Bn
API Access

Sanofi Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=SNY&period=max&api_key=YOUR_API_KEY